People | March 07, 2023
Aptar appoints Julie Xing to its Board of Directors
Julie is recognized as a highly engaging multi-cultural leader skilled in fluidly partnering with cross-functional teams to deliver results.
Julie is recognized as a highly engaging multi-cultural leader skilled in fluidly partnering with cross-functional teams to deliver results.
The company operates 25 CT Scanners, 6 new MRI Machines, 30 Pathological Laboratories, 1 Referral Laboratory, and 95 Collection Centers
She was the CEO of Tata Insights and Quants a Division of the Tata Industries Ltd.
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
Rocuronium Bromide Injection is a neuromuscular blocking agent
Jan Aushadhi highlights achievements of women of the country at 34 locations by felicitating all women stakeholders under the scheme
Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event
AstraZeneca and Merck are committed to working with the FDA to bring LYNPARZA in combination with abi/pred to patients diagnosed with mCRPC.
Sonowal exhorted young researchers and scientist to work on evidence based scientific research
Receives regulatory approval for its molecule ‘Selumetinib’ in India
Subscribe To Our Newsletter & Stay Updated
